These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37421800)

  • 1. Clinical Features, Treatment, and Prognostic Factors of Childhood-Onset Myasthenia Gravis in a Large Chinese Cohort.
    Bi Z; Ge H; Zhang Q; Gao H; Yang M; Zhan J; Lin J; Gui M; Li Y; Ji S; Cao Y; Bu B
    Pediatr Neurol; 2023 Sep; 146():31-39. PubMed ID: 37421800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis.
    Zhang J; Zhang Z; Zhang H; Cui Y; Chen Y; Lv P; Zhang P
    Orphanet J Rare Dis; 2022 Aug; 17(1):309. PubMed ID: 35945595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of 424 childhood-onset myasthenia gravis patients.
    Gui M; Luo X; Lin J; Li Y; Zhang M; Zhang X; Yang M; Wang W; Bu B
    J Neurol; 2015; 262(4):823-30. PubMed ID: 25588729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immune-related factors associated with exacerbation in adults with well-controlled generalized myasthenia gravis.
    Bi Z; Zhan J; Zhang Q; Gao H; Yang M; Ge H; Gui M; Lin J; Bu B
    Front Immunol; 2023; 14():1177249. PubMed ID: 37266422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of thymectomy in myasthenia gravis patients with thymus hyperplasia.
    Yang J; Liu C; Li T; Li C
    Int J Neurosci; 2017 Sep; 127(9):785-789. PubMed ID: 27819773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Autoimmune Ocular Myasthenia Gravis: Evaluation of Presentation and Treatment Outcomes in a Large Cohort.
    Fisher KS; Gill J; Todd HF; Yang MB; Lopez MA; Abid F; Lotze T; Shah VS
    Pediatr Neurol; 2021 May; 118():12-19. PubMed ID: 33684630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
    Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
    Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Juvenile Myasthenia Gravis in Southern China.
    Huang X; Li Y; Feng H; Chen P; Liu W
    Front Neurol; 2018; 9():77. PubMed ID: 29535672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV-V) generalized myasthenia gravis: is the game really worth the candle?
    Brascia D; Lucchi M; Aprile V; Guida M; Ricciardi R; Rea F; Comacchio GM; Schiavon M; Marino MC; Margaritora S; Meacci E; Spagni G; Evoli A; Lorenzoni G; De Iaco G; De Palma A; Marulli G
    Eur J Cardiothorac Surg; 2023 May; 63(5):. PubMed ID: 37162377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognosis of thymectomy in treatment of ocular myasthenia gravis and relevant influencing factors].
    Deng Y; Zhang X
    Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(27):1922-5. PubMed ID: 19953918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Affecting Generalization of Ocular Myasthenia Gravis in Patients With Positive Acetylcholine Receptor Antibody.
    Apinyawasisuk S; Chongpison Y; Thitisaksakul C; Jariyakosol S
    Am J Ophthalmol; 2020 Jan; 209():10-17. PubMed ID: 31562855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic predictors of remission in ocular myasthenia gravis.
    Çelebisoy N; Orujov A; Balayeva F; Özdemir HN; Ak AK; Gökçay F
    Acta Neurol Belg; 2023 Oct; 123(5):1927-1932. PubMed ID: 36474006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
    Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
    Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different neurologic outcomes of myasthenia gravis with thymic hyperplasia and thymoma after extended thymectomy: A single center experience.
    Zheng Y; Cai YZ; Shi ZY; Qiu Y; Zhang HL; Wang ZH; Li WB; Wang Y
    J Neurol Sci; 2017 Dec; 383():93-98. PubMed ID: 29246632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
    Allen JA; Scala S; Jones HR
    Muscle Nerve; 2010 Mar; 41(3):379-84. PubMed ID: 19918767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymectomy in ocular myasthenia gravis before generalization results in a higher remission rate.
    Li F; Li Z; Chen Y; Bauer G; Uluk D; Elsner A; Swierzy M; Ismail M; Meisel A; Rückert JC
    Eur J Cardiothorac Surg; 2020 Mar; 57(3):478-487. PubMed ID: 31628812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thymectomy in thymomatous and non-thymomatous myasthenia gravis: analysis of a cohort of 46 patients].
    Cabrera-Maqueda JM; Alba-Isasi MT; Hernández R; Arroyo-Tristán A; Morales-Ortiz A
    Rev Neurol; 2020 Mar; 70(6):213-219. PubMed ID: 32149381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.